IP Library › Granted Patent US 10,206,971
Granted Patent B2
US 10,206,971 · App. 14/995,868 · Granted Feb 19, 2019

Suspensions of cyclosporin A form 2

Inventors: Anuradha V. Gore (Irvine, CA); Prem Swaroop Mohanty (Irvine, CA); E. Quinn Farnes (Laguna Beach, CA)
Assignee: Allergan, Inc.
A61K38/13A61K9/0014A61K9/0048A61K9/14A61K47/06A61K47/10A61K47/26C07K7/645
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,206,971
App. No.
14/995,868
Granted
Feb 19, 2019
Kind
B2
Abstract

Disclosed herein are methods of formulating cyclosporin A Form 2.

Claims (3)

1. A method of treating a condition selected from dry eye, blepharitis, meibomian gland disease, impaired corneal sensitivity, allergic conjunctivitis, atopic keratoconjunctivitis, vernal keratoconjunctivitis, and pterygia, the method comprising the step of administering to a patient having such a condition a formulation comprising particles of cyclosporin A form 2 and a vehicle, wherein the average size (d90) of the particles is less than about 10 μm.

2. The method of claim 1 , wherein the average size of the particles is less than about 1 μm.

3. The method of claim 1 , wherein the condition is dry eye.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2016
From: GORE, ANURADHA V.; MOHANTY, PREM SWAROOP; FARNES, E. QUINN
To: ALLERGAN, INC.
Reel/Frame 037494/0033 →
Continuity (4)
Continuation 14325167 · Jul 7, 2014
Division 13677014 · Nov 14, 2012
Provisional Application 61559866 · Nov 15, 2011
Related Publication 20160129074A1 · May 12, 2016